MolNFT v1 · #103623 · protein
Crystal structure of ctx-M-14 S70G:S237A in complex with cefotaxime at 1.29 ångströms resolution
4PM7 · Beta-lactamase ctx-M-14: “Crystal structure of ctx-M-14 S70G:S237A in complex with cefotaxime at 1.29 ångströms resolution”. X-ray diffraction, 1 ligand (CE3), 1 pocket (best druggability 0.36). MolNFT v1 #103623 on GenesisL1: 3D…
- PDB
- 4PM7
- Type
- protein
- Length
- 263 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Beta-lactamase ctx-M-14
- UniProt
- G8XD06
- Ligands
- CE3
- Pockets
- 1 · best druggability 0.36
Structure
x-ray diffraction · 1 distinct chain · 43% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Beta-lactamase ctx-M-14 | protein | 263 | 43% helix, 19% strand | G8XD06 |
Ligands and binding sites
- CE3 · (6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 105 | 0.36 | 0.75 | 21 | CE3 |
Compared structures
- 4PM7 · Crystal structure of CTX-M-14 S70G:S237A in complex with cefotaxime at 1.29 Angstroms… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt G8XD06
- Elsewhere: RCSB PDB 4PM7 · PDBe 4PM7 · UniProt G8XD06
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.